Congenital Adrenal Hyperplasia: 11β-Hydroxylase Deficiency

Michael Peter

doi:10.1055/s-2002-35389

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2002; 20(3): 249-254
DOI: 10.1055/s-2002-35389

Congenital Adrenal Hyperplasia: 11β-Hydroxylase Deficiency

Michael Peter

SANITAS Ostseeklinik Boltenhagen and Division of Paediatric Endocrinology, Department of Paediatrics, University of Kiel, Kiel, Germany

Abstract

ABSTRACT

The most potent corticosteroids are 11β-hydroxylated compounds. In humans, two cytochrome P450 isoenzymes with 11β-hydroxylase activity, catalyzing the biosynthesis of cortisol and aldosterone, are present in the adrenal cortex. CYP11B1, the gene encoding 11β-hydroxylase (P450c11), is expressed in high levels in the zona fasciculata and is regulated by adrenocorticotropic hormone (ACTH). CYP11B2, the gene encoding aldosterone synthase (P450c11Aldo), is expressed in the zona glomerulosa under primary control of the renin-angiotensin system. The substrate for P450c11 is 11-deoxycortisol. Mutations in CYP11B1 cause congenital adrenal hyperplasia (CAH) due to 11β-hydroxylase deficiency. This disorder is characterized by androgen excess and hypertension and is autosomal recessively inherited. Classical and nonclassical forms of 11β-hydroxylase deficiency can be distinguished. Studies in heterozygotes for classical 11β-hydroxylase deficiency show inconsistent results with no or only mild hormonal abnormalities (elevated plasma levels of 11-deoxycortisol after ACTH stimulation). Molecular genetic studies of the CYP11B1 gene in 11β-hydroxylase deficiency have led to the identification of several mutations. Transfection experiments showed loss of enzyme activity in vitro. Molecular genetic studies have practical importance for the prenatal diagnosis of virilizing CAH forms.

KEYWORDS

Congenital adrenal hyperplasia - 11β-hydroxylase deficiency

Volltext

Referenzen

REFERENCES

1 Eberlein W R, Bongiovanni A M. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem . 1956; 223 85-94
2 Miller W L. Molecular biology of steroid hormone biosynthesis. Endocr Rev . 1988; 9 295-318
3 Curnow K M, Tusie-Luna M T, Pascoe L. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol . 1991; 5 1513-1522
4 Kawamoto T, Mitsuuchi Y, Toda K. Role of steroid 11β-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A . 1992; 89 1458-1462
5 White P C, Curnow K M, Pascoe L. Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev . 1994; 15 421-438
6 Mornet E, Dupont J, Vitek A, White P C. Characterization of two genes encoding human steroid 11β-hydroxylase (P-45011b). J Biol Chem . 1989; 264 20961-20967
7 Chua S C, Szabo P, Vitek A. Cloning of cDNA encoding steroid 11β-hydroxylase (P450c11). Proc Natl Acad Sci U S A . 1987; 84 7193-7197
8 Taymans S E, Pack S, Pak E. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3 J Clin Endocrinol Metab . 1998; 83 1033-1036
9 Nelson D R, Kamataki T, Waxman D J. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol . 1993; 12 1-51
10 Kawamoto T, Mitsuuchi Y, Toda K. Cloning of cDNA and genomic DNA for human cytochrome P-45011β. FEBS Lett . 1990; 269 345-349
11 Lala D S, Rice D A, Parker K L. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol . 1992; 6 1249-1258
12 Pang S Y, Wallace M A, Hofman L. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics . 1988; 81 866-874
13 Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: a study of 25 patients. J Clin Endocrinol Metab . 1983; 56 222-229
14 Rösler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11β-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet . 1992; 42 827-834
15 Hochberg Z, Schechter J, Benderly A, Leiberman E, Rösler A. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Am J Dis Child . 1985; 139 771-776
16 Carmina E, Malizia G, Pagano M, Janni A. Prevalence of late-onset 11β-hydroxylase deficiency in hirsute patients. J Endocrinol Invest . 1988; 11 595-598
17 Azziz R, Boots L R, Parker C R, Bradley E, Zacur H A. 11β-hydroxylase deficiency in hyperandrogenism. Fertil Steril . 1991; 55 733-741
18 Joehrer K, Geley S, Strasser-Wozak E MC. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β-hydroxylase deficiency. Hum Mol Genet . 1997; 6 1829-1834
19 Rösler A, Leiberman E, Sack J. Clinical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Horm Res . 1982; 16 133-141
20 Hague W M, Honour J W. Malignant hypertension in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Clin Endocrinol (Oxf) . 1983; 18 505-510
21 Zadik Z, Kahana L, Kaufmann H, Benderly A, Hochberg Z. Salt loss in hypertensive form of congenital adrenal hyperplasia (11β-hydroxylase deficiency). J Clin Endocrinol Metab . 1984; 58 384-387
22 Hochberg Z, Benderly A, Kahana L, Zadik Z. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. J Clin Endocrinol Metab . 1986; 63 36-40
23 Levine L S, Rauh W, Gottesdiener K. New studies of the 11β-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab . 1980; 50 258-263
24 Pang S, Levine L S, Lorenzen F. Hormonal studies in obligate heterozygotes and siblings of patients with 11β-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab . 1980; 50 586-589
25 Rösler A, Cohen H. Absence of steroid biosynthetic defects in heterozygote individuals for classic 11β-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene. J Clin Endocrinol Metab . 1995; 80 3771-3773
26 Peter M, Sippell W G. Evidence for endocrinological abnormalities in heterozygotes for adrenal 11β-hydroxylase deficiency of a family with the R448H mutation in the CYP11B1 gene. J Clin Endocrinol Metab . 1997; 82 3506-3508
27 Wudy S A, Homoki J, Wachter U A, Teller W M. Diagnosis of congenital adrenogenital hyperplasia due to 11β-hydroxylase deficiency by gas chromatographic and mass spectrometric analysis of urinary steroids. Dtsch Med Wochenschr . 1997; 122 3-11
28 Honour J W, Anderson J M, Shackleton C H. Difficulties in the diagnosis of congenital adrenal hyperplasia in early infancy: the 11β-hydroxylase defect. Acta Endocrinol (Copenh) . 1983; 103 101-109
29 Rösler A, Weshler N, Leiberman E. 11β-hydroxylase deficiency congenital adrenal hyperplasia: update of prenatal diagnosis. J Clin Endocrinol Metab . 1988; 66 830-838
30 Schumbert Z, Rosemann A, Landa H, Rösler A. 11-Deoxycortisol in amniotic fluid: prenatal diagnosis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Clin Endocrinol (Oxf) . 1980; 12 257-260
31 Sippell W G, Müller-Holve W, Dörr H G, Bidlingmaier F KD. Concentrations of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation. J Clin Endocrinol Metab . 1981; 52 385-392
32 Cerame B I, Newfield R S, Pascoe L. Prenatal diagnosis and treatment of 11β-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab . 1999; 84 3129-3134
33 Curnow K M, Slutsker L, Vitek J. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A . 1993; 90 4552-4556
34 Geley S, Kapelari K, Joehrer K. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab . 1996; 81 2896-2901
35 Forest M G, Morel Y, David M. Prenatal treatment of congenital adrenal hyperplasia. TEM . 1998; 9 284-289
36 White P C, Dupont J, New M I. A mutation in CYP11B1 (Arg-448→His) associated with steroid 11β-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest . 1991; 87 1664-1667
37 Helmberg A, Ausserer B, Kofler R. Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab . 1992; 75 1278-1281
38 Naiki Y, Kawamoto T, Mitsuuchi Y. A nonsense mutation (TGG [Trp116] → TAG [Stop]) in CYP11B1 causes steroid 11β-hydroxylase deficiency. J Clin Endocrinol Metab . 1993; 77 1677-1682
39 Skinner C A, Rumsby G. Steroid 11β-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Hum Mol Genet . 1994; 3 377-378
40 Yang L X, Toda K, Miyahara K. Classic steroid 11β-hydroxylase deficiency caused by a C → G transversion in exon 7 of CYP11B1. Biochem Biophys Res Commun . 1995; 216 723-728
41 Skinner C A, Rumsby G, Honour J W. Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene. J Clin Endocrinol Metab . 1996; 81 2389-2393
42 Nakagawa Y, Yamada M, Ogawa H, Igarashi Y. Missense mutation in CYP11B1 (CGA[Arg-384] → GGA[Gly]) causes steroid 11β-hydroxylase deficiency. Eur J Endocrinol . 1995; 132 286-289
43 Merke D P, Tajima T, Chhabra A. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency. Clin Endocrinol Metab . 1998; 83 270-273
44 Viemann M, Peter M, Schwarz H P, Sólyom J, Sippell W G. CYP11B1 gene mutations in patients with 11β-hydroxylase deficiency. Horm Res . 1998; 50(S3) 108
45 Chabre O, Portrat-Doyen S, Chaffanjon P. Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1 J Clin Endocrinol Metab . 2000; 85 4060-4068
46 Portrat S, Mulatero P, Curnow K M. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase) cause steroid 11β-hydroxylase deficiency and congenital adrenal hyperplasia. J Clin Endocrinol Metab . 2001; 86 3197-3201
47 Hampf M, Dao N T, Hoan N T, Bernhardt R. Unequal crossing-over between aldosterone synthase and 11β-hydroxylase genes causes congenital adrenal hyperplasia. J Clin Endocrinol Metab . 2001; 86 4445-4452